These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 11412622

  • 1. [Current in vitro sensitivity of the most frequent bacterial respiratory pathogens: clinical implications].
    Oteo J, Alós JI, Gómez-Garcés JL.
    Med Clin (Barc); 2001 Apr 21; 116(14):541-9. PubMed ID: 11412622
    [No Abstract] [Full Text] [Related]

  • 2. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE, Lindmark A, Persson I.
    J Chemother; 1989 Jul 21; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract] [Full Text] [Related]

  • 3. Microbiological profile of telithromycin, the first ketolide antimicrobial.
    Felmingham D.
    Clin Microbiol Infect; 2001 Jul 21; 7 Suppl 3():2-10. PubMed ID: 11523558
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment with appropriate antibiotic therapy in community-acquired respiratory tract infections.
    Nicolau DP.
    Am J Manag Care; 2004 Oct 21; 10(12 Suppl):S381-8. PubMed ID: 15603247
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [In vitro activity of trovafloxacin in 238 respiratory pathogens].
    Alarcón T, Domingo D, Prieto N, Sánchez S, López-Brea M.
    Rev Esp Quimioter; 1998 Mar 21; 11(1):47-51. PubMed ID: 9795289
    [Abstract] [Full Text] [Related]

  • 12. Comparative antimicrobial activity of the new macrolide flurithromycin against respiratory pathogens.
    Nord CE, Lindmark A, Persson I.
    Eur J Clin Microbiol Infect Dis; 1988 Feb 21; 7(1):71-3. PubMed ID: 3132384
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Resistance patterns of selected respiratory tract pathogens in Poland.
    Skoczyńska A, Kadłubowski M, Waśko I, Fiett J, Hryniewicz W.
    Clin Microbiol Infect; 2007 Apr 21; 13(4):377-83. PubMed ID: 17359321
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial resistance of respiratory pathogens isolated from pediatric patients.
    Zarakolu P, Unal S.
    J Chemother; 2006 Oct 21; 18(5):565-6. PubMed ID: 17127238
    [No Abstract] [Full Text] [Related]

  • 17. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR, Huang WK, Shyr JM, Lau YJ, Liu YC, Luh KT.
    J Formos Med Assoc; 2004 Sep 21; 103(9):664-70. PubMed ID: 15361938
    [Abstract] [Full Text] [Related]

  • 18. In vitro potency of nine orally administered antimicrobial agents against three respiratory tract pathogens.
    Barry AL.
    Eur J Clin Microbiol Infect Dis; 1992 Sep 21; 11(9):867-9. PubMed ID: 1468431
    [No Abstract] [Full Text] [Related]

  • 19. Postantibiotic effect of ceftibuten on respiratory pathogens.
    Chin NX, Huang HB, Neu HC.
    Pediatr Infect Dis J; 1995 Jul 21; 14(7 Suppl):S84-7. PubMed ID: 7567315
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of faropenem against respiratory pathogens.
    du Plessis M, Capper TP, Klugman KP.
    J Antimicrob Chemother; 2002 Mar 21; 49(3):575-7. PubMed ID: 11864964
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.